Astra ends production of asthma inhaler
Newsday (subscription) By AP (AP) — AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma, … SkyePharma Shares Fall As AstraZeneca Drops Asthma Product SkyePharma crashes AZ discontinues inhaler on 'technical issues' |
View full post on asthma – Google News